Testing a stool transplant for diabetes and heart disease
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether transferring healthy stool bacteria into your gut (called fecal microbiota transplantation) can help improve blood sugar control and heart health in people with type 2 diabetes and heart disease. It is a small, early-stage study to see if the treatment is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have type 2 diabetes and stable heart disease (coronary artery disease).
- You must be willing to have a colonoscopy to receive the transplant.
- You cannot have had a heart attack in the last 12 months.
- You cannot have taken antibiotics in the last 3 months, and you cannot be on steroids or other immune-suppressing drugs.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help improve blood sugar and thyroid antibody levels in people with type 2 diabetes and Hashimoto's thyroiditis. If you qualify, you might get a chance to try this new approach.
This trial tests whether a stool transplant, which introduces healthy bacteria into the gut, can improve symptoms and quality of life in older adults with a type of heart failure where the heart's pumping function is preserved but filling is impaired. It may help because the gut bacteria can affect inflammation and heart health.
This trial tests if a washed microbiota transplant (a processed stool transplant from healthy donors) can help people with type 1 diabetes. It aims to see if this treatment can improve blood sugar control or reduce the need for insulin.
This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.